Aberrant methylation of tumor suppressor genes and allelic imbalance in cervical intraepithelial neoplasia

Molecular Biology

Volumn 40, Issue 2, 2006, Pages 194-199

  Kekeeva, T V ^a,b   Zhevlova, A I ^b   Podistov, Yu I ^c   Solov'eva, Yu V ^d   Zaletaev, D V ^a,b   Nemtsova, M V ^a,b  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d Clinical Hospital No 70   (Russian Federation)

Author keywords

Aberrant methylation; Carcinogenesis; Dysplasia; Microsatellite instability; Tumor suppressor genes

Indexed keywords

EID: 33646527989     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893306020038     Document Type: Article

References (33)

1. Heilmann V., Kreienberg R. 2002. Molecular biology of cervical cancer and its precursors. Curr. Womens Health Rep. 2, 27-33.
2. House M., Guo M., Iacobuzio-Donahue C., Herman J. 2003. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms of the pancreas. Carcinogenesis. 24, 193-198.
3. Maruyama R., Toyooka S., Toyooka K., et al. 2002. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 8, 514-519.
4. Muller H., Fiegl H., Widschwendter A., Widschwendter M. 2004. Prognostic DNA methylation marker in serum of cancer patients. Ann. N.Y. Acad. Sci. 1022, 44-49.
5. Zaletaev D., Nemtsova M., Strel'nikov V., et al. 2004. Diagnostics of epigenetic alterations in heredirtary and oncological disorders. Mol. Biol. 38, 213-223.
6. Sutter C., Gebert J., Bischoff P., et al. 1999 Molecular screening of potential HNPCC patients using multiplex microsatellite PCR system. Mol. Cell. Probes. 13, 157-165.
7. Chen X., Stroun M., Magnenat J., et al. 1996. Microsatellite alterations in plasma DNA of small-cell lung cancer patients. Nature Med. 2, 1033-1035.
8. Gurin C., Federichi M., Kang L., Boyd J. 1999. Causes and consequences of MSI in endometrial carcinoma. Cancer Res. 59, 462-466.
9. Knobloch R., Konrad L., Barth P., et al. 2004. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping. Clin. Cancer Res. 10, 1064-1073.
10. Gorgoulis V., Mariatos G., Manolis E., et al. 2000. Allelic imbalance at the 5q14 locus associated with decreased apoptotic rate in NSCLCs. Possible synergistic effect with p53 gene alterations on apoptosis. Lung Cancer. 28, 211-224.
11. Girard L., Zochbauer-Muller S., Virmani A., et al. 2000. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between SCLC and NSCLC, and loci clustering. Cancer Res. 60, 4894-4906.
12. Wong C., Lee J., Lau T., et al. 2002. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma. Clin. Cancer Res. 8, 2266-2272.
13. Zemlyakova V., Zhevlova A., Zborovskaya I., et al., 2003. Methylation profile of several tumor suppressor genes in non-small-cell lung cancer. Mol. Biol. 37, 983-988.
14. Zemlyakova, V., Zhevlova, A., Strel'nikov, V., et al. 2003. Abnormal methylation of several tumor suppressor genes in sporadic breast cancer. Mol. Biol. 37, 696-703.
15. Ballestar E., Esteller M. 2002. The impact of chromatin in human cancer linking DNA methylation to gene silencing. Carcinogenesis. 23, 1103-1109.
16. Malyukova A., Loginov V., Khodyrev D., et al. 2004. Methylation of the putative tumor suppressor gene RASSF1A in primary cervical tumors. Mol. Biol. 38, 1005-1013.
17. Narayan G., Arias-Pulido H., Koul S., et al. 2003. Frequent promoter methylation of CDH1, DAPK, RARB and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome. Mol. Cancer. 2, 24.
18. Virmani A., Muller C., Rathi A., et al. 2001. Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7, 584-589.
19. Dong S., Kim H., Rha S., Sidransky D. 2001. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res. 7, 1982-1986.
20. Widschwendter A., Muller H., Fiegl H., et al. 2004. DNA methylation in serum and tumors of cervical cancer patients. Clin. Cancer Res. 10, 565-571.
21. Reesink-Peters N., Wisman G., Jeronimo C., et al. 2004. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: A feasibility study. Mol. Cancer Res. 2, 289-295.
22. Waki T., Tamara G., Makoto S., Motoyama T. 2003. Age-related methylation of tumor-supressor and tumor-related genes: An analysis of autopsy samples. Oncogene. 22, 4128-4133.
23. Feng Q., Balasubramanian A., Hawes S., et al. 2005. Detection of hypermethylated genes in women with and without cervical neoplasia. J. Natl. Cancer Inst. 97, 273-282.
24. Herman J., Merlo A., Mao L., et al. 1995 Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with abberant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530.
25. Kondo Y., Shen L., Issa J. 2003. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell Biol. 23, 206-215.
26. Uehara E., Takeuchi S., Tasaka T., et al. 2003. Aberrant methylation in CpG islands of multiple genes in therapy-related leukemia. Int. J. Oncol. 23, 693-696.
27. Leung J., Yuen S., Chung L., et al. 1999. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 59, 159-164.
28. Baylin S., Herman J., Graff J., et al. 1998. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196.
29. Lee S., Lee H., Kim J., et al. 2003. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am. J. Pathol. 163, 1371-1378.
30. Zochbauer-Muller S., Fong K., Virmani A., et al. 2001. Aberrant promoter methylation of multiple genes in non-small-cell lung cancers. Cancer Res. 61, 249-255.
31. Bhowmick N., Neilson E., Moses H. 2004. Stromal fibroblasts in cancer initiation and progression. Nature. 432, 332-337.
32. Heselmeyer K., Schrock E., Manoir S., et al. 1996. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA 93, 479-484.
33. Chung T., Cheung T., Lo W., et al. 2000. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepitelial neoplasia. Cancer Lett. 154, 189-194.